Drug Profile
Cariporide
Alternative Names: HOE 604; HOE 642Latest Information Update: 27 May 2003
Price :
$50
*
At a glance
- Originator Aventis
- Class Anti-ischaemics; Guanidines; Small molecules; Sulfones
- Mechanism of Action Sodium hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders; Myocardial infarction; Unstable angina pectoris
Most Recent Events
- 16 May 2003 Discontinued - Phase-II for Arrhythmias in Germany (IV-injection)
- 16 May 2003 Discontinued - Phase-II for Myocardial infarction in Europe (unspecified route)
- 16 May 2003 Discontinued - Phase-II for Myocardial infarction in Japan (unspecified route)